Ovid Therapeutics Inc. (OVID) has 16 open-market insider trades by 8 insiders since 2017. The most active filer is Jeremy M. Levin, Chairman.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Takeda Pharmaceutical Co. Ltd. | 10% Owner | — | 1 | $5.0M | 2022-07-01 |
| Jeremy M. Levin | Chairman | — | 5 | $670K | 2026-03-23 |
| Amit Rakhit | PresCMO | — | 1 | $252K | 2021-07-14 |
| Karen Bernstein | Dir | — | 2 | $145K | 2019-02-26 |
| Jason Tardio | COO | — | 1 | $37K | 2024-02-22 |
| Douglas E. Williams | Dir | — | 1 | $32K | 2018-08-14 |
| Margaret A. Alexander | Pres | — | 3 | $25K | 2026-02-23 |
| Jeffrey A. Rona | CBFO | — | 2 | $15K | 2026-02-26 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Margaret A. Alexander | President | Sell | $17K | 2026-02-23 |
| Jeffrey A. Rona | CBFO | Sell | $12K | 2026-02-23 |
| Margaret A. Alexander | President | Sell | $3K | 2025-02-26 |
| Jeffrey A. Rona | CBFO | Sell | $2K | 2025-02-26 |
| Margaret A. Alexander | President | Buy | $5K | 2025-01-27 |
| Jeremy M. Levin | CEO | Buy | $101K | 2024-03-18 |
Companies that share insiders with OVID, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Jason Tardio | COO | Sell | $37K | 2022-09-12 |
| Amit Rakhit | President & CMO | Sell | $252K | 2021-07-14 |
| Jeremy M. Levin | CEO & 10% | Buy | $50K | 2020-08-28 |
| Takeda Pharmaceutical Co. Ltd. | 10% Owner | Buy | $5.0M | 2019-10-08 |
| Jeremy M. Levin | CEO | Buy | $150K | 2019-10-08 |
| Karen Bernstein | Director | Buy | $20K | 2019-02-26 |
| Jeremy M. Levin | CEO | Buy | $150K | 2019-02-22 |
| Douglas E. Williams | Director | Buy | $32K | 2018-08-14 |
| Karen Bernstein | Director | Buy | $125K | 2018-08-14 |